In a Red TV interview, RHU Provost and Professor of Microbiology Dr. Mahmoud Halablab discussed the ongoing Ebola outbreak and international efforts to contain the virus.
During the interview, Dr. Halablab emphasized the severity of Ebola, noting that some strains can have mortality rates significantly higher than those seen in the early stages of the COVID-19 pandemic. He explained that delays in diagnosing the initial case, due to limited laboratory capacity and the need to transport samples over long distances for testing, contributed to the spread of the disease.
Dr. Halablab outlined the characteristics of the major Ebola strains, including the Bundibugyo, Sudan, and Zaire strains, noting that the Zaire strain is considered the most lethal. He also discussed ongoing efforts to develop vaccines that provide protection against multiple Ebola strains.
Addressing transmission risks, Dr. Halablab emphasized that Ebola spreads through direct contact with infected individuals, contaminated surfaces, and bodily fluids, not through the air. He stressed the importance of early case detection, isolation, contact tracing, safe burial practices, hand hygiene, and public health surveillance to control outbreaks.
Dr. Halablab further noted that the virus has an incubation period of up to 21 days, making contact monitoring a critical part of outbreak response. He expressed confidence in Lebanon's preparedness to respond to potential cases, citing the country's healthcare expertise and the valuable experience gained during the COVID-19 pandemic.
The discussion also addressed the potential implications of increased international travel linked to major global events, including the upcoming FIFA World Cup. Dr. Halablab noted that the high volume of daily international air travel can heighten the risk of cross-border disease transmission if outbreaks are not effectively contained. He emphasized the importance of rigorous surveillance, screening, and international cooperation to minimize public health risks while facilitating global mobility.
Dr. Halablab's participation reflects RHU's commitment to public health awareness and to contributing scientific expertise to issues of global significance.
Watch the interview here.